pbtz169 and Tuberculosis--Pulmonary

pbtz169 has been researched along with Tuberculosis--Pulmonary* in 1 studies

Other Studies

1 other study(ies) available for pbtz169 and Tuberculosis--Pulmonary

Article	Year
Macozinone: revised synthesis and crystal structure of a promising new drug for treating drug-sensitive and drug-resistant tuberculosis. Acta crystallographica. Section C, Structural chemistry, 2019, 08-01, Volume: 75, Issue:Pt 8 Mycobacterium tuberculosis (Mtb), the principal etiological agent of tuberculosis (TB), infects over one-quarter of humanity and is now the leading cause of infectious disease mortality by a single pathogen. Macozinone {2-[4-(cyclohexylmethyl)piperazin-1-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one, C Topics: Antitubercular Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Hydrogen Bonding; Molecular Conformation; Piperazines; Thiazines; Tuberculosis, Pulmonary	2019

Article

Year

Macozinone: revised synthesis and crystal structure of a promising new drug for treating drug-sensitive and drug-resistant tuberculosis.

Acta crystallographica. Section C, Structural chemistry, 2019, 08-01, Volume: 75, Issue:Pt 8

Mycobacterium tuberculosis (Mtb), the principal etiological agent of tuberculosis (TB), infects over one-quarter of humanity and is now the leading cause of infectious disease mortality by a single pathogen. Macozinone {2-[4-(cyclohexylmethyl)piperazin-1-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one, C

Topics: Antitubercular Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Hydrogen Bonding; Molecular Conformation; Piperazines; Thiazines; Tuberculosis, Pulmonary

2019